My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 167

    1.

    Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.

    Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D; Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Apr;32(4):726-32. Epub 2009 Jan 26.PMID: 19171717 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Apr;28(4):888-94.PMID: 15793191 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

    Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

    Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947. PMID: 11874944 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

    Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program.

    Diabetes. 2008 Apr;57(4):980-6. Epub 2008 Jan 11.PMID: 18192541 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

    Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

    Am J Clin Nutr. 2009 Sep;90(3):595-601. Epub 2009 Jul 29.PMID: 19640960 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

    Nagi DK, Yudkin JS.

    Diabetes Care. 1993 Apr;16(4):621-9.PMID: 8462390 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

    10.

    The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?

    Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES.

    Diabetes Care. 2003 Nov;26(11):3024-30.PMID: 14578234 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Relationship of body size and shape to the development of diabetes in the diabetes prevention program.

    [No authors listed]

    Obesity (Silver Spring). 2006 Nov;14(11):2107-17.PMID: 17135629 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Progress in the prevention of type 2 diabetes]

    Schernthaner G.

    Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German. PMID: 14743578 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

    Unwin N, Shaw J, Zimmet P, Alberti KG.

    Diabet Med. 2002 Sep;19(9):708-23. Review.PMID: 12207806 [PubMed - indexed for MEDLINE]Related articles

    15.

    Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

    Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

    Diabetes Care. 2008 Jul;31(7):1416-21. Epub 2008 Mar 20.PMID: 18356403 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.

    Andreadis EA, Katsanou PM, Georgiopoulos DX, Tsourous GI, Yfanti GK, Gouveri ET, Diamantopoulos EJ.

    Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):175-80. Epub 2008 Dec 3.PMID: 19053032 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

    Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM.

    Metabolism. 2004 Feb;53(2):159-64.PMID: 14767866 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.

    Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Sep;32(9):1583-8. Epub 2009 Jul 8.PMID: 19587364 [PubMed - indexed for MEDLINE]Related articles

    19.

    Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.

    Snehalatha C, Mary S, Joshi VV, Ramachandran A.

    Diab Vasc Dis Res. 2008 Mar;5(1):25-9.PMID: 18398809 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.

    Freemark M, Bursey D.

    Pediatrics. 2001 Apr;107(4):E55.PMID: 11335776 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity